Hancock Jaffe Laboratories Inc Ordinary Shares (NASDAQ:HJLI)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - HJLI

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - HJLI

  • Market Cap$51.250m
  • IndustryHealthcare
  • SectorMedical Devices
  • Currency
  • ISINUS41015N3044

Company Profile

Hancock Jaffe Laboratories Inc is a medical device company developing tissue-based solutions that are designed to be life-sustaining or life-enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat a debilitating condition called chronic venous insufficiency (CVI); and the CoreoGraft, a bovine based conduit to be used to revascularize the heart during coronary artery bypass graft (CABG) surgeries.Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.

Latest HJLI news

Currently there for this company. Visit our news hub for other news .